Jonna Niskanen
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
IFNγ alters the aberrant phenotype of α-synuclein-treated microglia reducing the detrimental impact of their secretome on dopaminergic neurons.
Journal: Neuroscience
Published: January 21, 2026
Activation of steroid hormone receptors by metabolism-disrupting chemicals.
Journal: Toxicology and applied pharmacology
Published: February 07, 2025
LRRK2 G2019S Mutated iPSC-Derived Endothelial Cells Exhibit Increased α-Synuclein, Mitochondrial Impairment, and Altered Inflammatory Responses.
Journal: International journal of molecular sciences
Published: October 04, 2024
Mutated LRRK2 induces a reactive phenotype and alters migration in human iPSC-derived pericyte-like cells.
Journal: Fluids and barriers of the CNS
Published: September 17, 2024
Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson's disease related transcriptional profile and function.
Journal: Scientific reports
Published: July 31, 2023
Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
Journal: International journal of molecular sciences
Published: April 08, 2021
Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR.
Journal: Cells
Published: September 15, 2020
The EDCMET Project: Metabolic Effects of Endocrine Disruptors.
Journal: International journal of molecular sciences
Published: March 30, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026